These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 9147276)
21. Molecular characterization and antifungal susceptibility of Cryptococcus neoformans strains collected from a single institution in Lima, Peru. Bejar V; Tello M; García R; Guevara JM; Gonzales S; Vergaray G; Valencia E; Abanto E; Ortega-Loayza AG; Hagen F; Gutierrez EL Rev Iberoam Micol; 2015; 32(2):88-92. PubMed ID: 25556051 [TBL] [Abstract][Full Text] [Related]
22. Disseminated cryptococcosis in an AIDS patient caused by a canavanine-resistant strain of Cryptococcus neoformans var. grubii. Khan ZU; Al-Anezi AA; Chandy R; Xu J J Med Microbiol; 2003 Mar; 52(Pt 3):271-275. PubMed ID: 12621094 [TBL] [Abstract][Full Text] [Related]
23. Cryptococcus neoformans var. gattii among patients with cryptococcal meningitis in Mexico. First observations. López-Martínez R; Soto-Hernández JL; Ostrosky-Zeichner L; Castanón-Olivares LR; Angeles-Morales V; Sotelo J Mycopathologia; 1996; 134(2):61-4. PubMed ID: 8981772 [TBL] [Abstract][Full Text] [Related]
24. [Cryptococcosis caused by Cryptococcus neoformans var. Gattii. A case associated with acquired immunodeficiency syndrome (AIDS) in Kinshasa, Zaire]. Muyembe Tamfum JJ; Mupapa Kibadi D; Nganda L; Ngwala-Bikindu D; Kuezina T; Kela-We I; Vandepitte J Med Trop (Mars); 1992; 52(4):435-8. PubMed ID: 1494313 [TBL] [Abstract][Full Text] [Related]
25. Cryptococcal meningitis caused by Cryptococcus neoformans var. gattii, serotype C, in AIDS patients in Soweto, South Africa. Karstaedt AS; Crewe-Brown HH; Dromer F Med Mycol; 2002 Feb; 40(1):7-11. PubMed ID: 11860015 [TBL] [Abstract][Full Text] [Related]
26. Serotypes of Cryptococcus neoformans isolated from patients prior to and during the AIDS era in Thailand. Sukroongreung S; Nilakul C; Ruangsomboon O; Chuakul W; Eampokalap B Mycopathologia; 1996; 135(2):75-8. PubMed ID: 9063001 [TBL] [Abstract][Full Text] [Related]
27. Differentiation of Cryptococcus neoformans varieties and Cryptococcus gattii using CAP59-based loop-mediated isothermal DNA amplification. Lucas S; da Luz Martins M; Flores O; Meyer W; Spencer-Martins I; Inácio J Clin Microbiol Infect; 2010 Jun; 16(6):711-4. PubMed ID: 19694768 [TBL] [Abstract][Full Text] [Related]
29. Crytococcus neoformans var. gattii in an AIDS patient: first observation in Mexico. Castanón-Olivares LR; Lopez-Martínez R; Barriga-Angulo G; Ríos-Rosas C J Med Vet Mycol; 1997; 35(1):57-9. PubMed ID: 9061587 [TBL] [Abstract][Full Text] [Related]
30. Susceptibility profile and epidemiological cut-off values of Cryptococcus neoformans species complex from Argentina. Córdoba S; Isla MG; Szusz W; Vivot W; Altamirano R; Davel G Mycoses; 2016 Jun; 59(6):351-6. PubMed ID: 26865081 [TBL] [Abstract][Full Text] [Related]
31. [Cryptococcus neoformans chemotyping. Review of the literature. New epidemiologic data on cryptococcosis. Our experience with the use of C.G.B. media in the study of this yeast]. de Melo NT; Lacaz Cda S; Charbel CE; Pereira AD; Heins-Vaccari EM; França-Netto AS; Machado Ldos R; Livramento JA Rev Inst Med Trop Sao Paulo; 1993; 35(5):469-78. PubMed ID: 8115818 [TBL] [Abstract][Full Text] [Related]
32. Antifungal susceptibilities of Cryptococcus species complex isolates from AIDS and non-AIDS patients in Southeast China. Li M; Liao Y; Chen M; Pan W; Weng L Braz J Infect Dis; 2012; 16(2):175-9. PubMed ID: 22552461 [TBL] [Abstract][Full Text] [Related]
33. Cryptococcus neoformans var. gattii in India. Padhye AA; Chakrabarti A; Chander J; Kaufman L J Med Vet Mycol; 1993; 31(2):165-8. PubMed ID: 8509953 [TBL] [Abstract][Full Text] [Related]
34. Susceptibility profile of clinical and environmental isolates of Cryptococcus neoformans and Cryptococcus gattii in Uberaba, Minas Gerais, Brazil. Andrade-Silva L; Ferreira-Paim K; Mora DJ; Da Silva PR; Andrade AA; Araujo NE; Pedrosa AL; Silva-Vergara ML Med Mycol; 2013 Aug; 51(6):635-40. PubMed ID: 23343452 [TBL] [Abstract][Full Text] [Related]
35. Serotyping of Cryptococcus neoformans isolates from clinical and environmental sources in Spain. Baró T; Torres-Rodríguez JM; Morera Y; Alía C; López O; Méndez R J Clin Microbiol; 1999 Apr; 37(4):1170-2. PubMed ID: 10074545 [TBL] [Abstract][Full Text] [Related]
36. Serotype, mating type and ploidy of Cryptococcus neoformans strains isolated from patients in Brazil. Ohkusu M; Tangonan N; Takeo K; Kishida E; Ohkubo M; Aoki S; Nakamura K; Fujii T; Siqueira IC; Maciel EA; Sakabe S; Almeida GM; Heins-Vaccari EM; Lacaz Cda S Rev Inst Med Trop Sao Paulo; 2002; 44(6):299-302. PubMed ID: 12532211 [TBL] [Abstract][Full Text] [Related]
37. Identification and properties of plasma membrane azole efflux pumps from the pathogenic fungi Cryptococcus gattii and Cryptococcus neoformans. Basso LR; Gast CE; Bruzual I; Wong B J Antimicrob Chemother; 2015 May; 70(5):1396-407. PubMed ID: 25630649 [TBL] [Abstract][Full Text] [Related]
38. Cryptococcus neoformans serotype A and Cryptococcus gattii serotype B isolates differ in their susceptibilities to fluconazole and voriconazole. Khan ZU; Randhawa HS; Chehadeh W; Chowdhary A; Kowshik T; Chandy R Int J Antimicrob Agents; 2009 Jun; 33(6):559-63. PubMed ID: 19195846 [TBL] [Abstract][Full Text] [Related]
39. Environmental prevalence of Cryptococcus neoformans and Cryptococcus gattii in India: an update. Chowdhary A; Rhandhawa HS; Prakash A; Meis JF Crit Rev Microbiol; 2012 Feb; 38(1):1-16. PubMed ID: 22133016 [TBL] [Abstract][Full Text] [Related]
40. [Susceptibility to antifungal agents among Cryptococcus neoformans varieties isolated from patients at a university hospital]. Silva PR; Rabelo RA; Terra AP; Teixeira DN Rev Soc Bras Med Trop; 2008; 41(2):158-62. PubMed ID: 18545836 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]